Compounded vs. FDA-Approved BHRT: Cost and Access Differences
Understand compounded vs FDA approved BHRT cost, coverage, and access so you can make a confident, informed decision about your hormone therapy.
Jason Revilla
Founder & Lead Researcher, MyHormoneGuide
Compounded vs. FDA-Approved BHRT Cost: What You’re Really Paying For
If you’ve spent any time researching hormone therapy, you’ve already hit the wall: two paths, two price tags, and almost no clear explanation of the difference. The compounded vs. FDA-approved BHRT cost question is one of the most common — and most poorly answered — questions in the hormone space. You deserve a straight answer, not a sales pitch from a compounding pharmacy or a dismissive wave from a conventional doctor. This post breaks down exactly what each option costs, what you get for that money, and how to decide which path makes sense for your situation.
By the time you finish reading, you’ll understand how both options are priced, why insurance covers one and not the other, what hidden costs to watch for, and which scenario tends to favor each choice. Let’s get into it.
Understanding the Core Difference in Compounded vs. FDA-Approved BHRT Cost
The single biggest driver of cost difference between compounded and FDA-approved BHRT is insurance coverage — and it comes down to regulatory status. FDA-approved bioidentical hormones, such as estradiol patches (Vivelle-Dot, Climara), estradiol gel (Divigel, EstroGel), estradiol vaginal inserts (Vagifem, Imvexxy), and micronized progesterone (Prometrium), have gone through the FDA’s full drug approval process. That means clinical trials, manufacturing audits, and standardized potency testing. Because they are approved drugs, they appear on insurance formularies and Medicare Part D plans.
Compounded BHRT is mixed by a licensed pharmacist to a prescriber’s specific order. It is not FDA-approved as a finished product. Because it lacks that approval status, virtually no commercial insurance plan or Medicare plan will reimburse it. You pay out of pocket — every refill, every month.
That regulatory distinction doesn’t mean compounded BHRT is inherently inferior or dangerous. It means the cost calculus is fundamentally different. A patient with good prescription coverage might pay $10–$40 per month for an FDA-approved estradiol patch, while the same patient would pay $60–$150 per month for a comparable compounded cream — with zero insurance offset. If you’re curious about the regulatory nuances in more depth, our full guide on Is BHRT FDA-Approved? What Patients Need to Know walks through the approval landscape clearly.
What FDA-Approved Bioidentical Hormone Therapy Actually Costs
FDA-approved hormone therapy costs range from nearly free with good insurance to $200–$400 per month without it, depending entirely on your formulary tier and the specific product. Here’s how the numbers typically break down:
With insurance or Medicare Part D: Many estradiol patches and gels land on Tier 1 or Tier 2 formularies, meaning copays of $10–$40 per month are common. Prometrium (micronized progesterone) is similarly covered on most plans. Patients with employer-sponsored insurance or solid Medicare Part D plans often find FDA-approved BHRT to be extremely affordable.
Without insurance (cash pay or high-deductible plans): Out-of-pocket costs climb sharply. Brand-name estradiol patches can run $150–$350 per month at retail pharmacy prices. Generic versions and GoodRx-style discount programs can bring this down significantly — sometimes to $20–$60 for generics. Prometrium cash-pay price typically falls between $60–$120 per month depending on dose and pharmacy.
What drives the range: Delivery method matters. Patches and gels are generally less expensive than vaginal rings or pellets. Dose matters too — higher doses mean more product per refill.
The bottom line for FDA-approved options: if you have functional insurance coverage, this path is almost always the lowest total out-of-pocket cost. If you’re uninsured or underinsured, the gap between compounded and FDA-approved narrows considerably.
What Compounded BHRT Actually Costs
Compounded BHRT prices typically range from $30 to $250 per month, with the average patient spending $80–$150 monthly out of pocket. The wide range reflects real variation in what’s being compounded. Here’s what shapes the price:
Hormone complexity: A simple compounded estradiol cream costs less than a tri-estrogen formula (Bi-Est or Tri-Est) combining estriol, estradiol, and sometimes estrone. Adding testosterone or DHEA to a base formula increases cost.
Delivery form: Topical creams and gels tend to be the most affordable compounded options. Sublingual troches (dissolving tablets) are similarly priced. Compounded injectable hormones and pellets represent the higher end — pellet insertion fees alone can run $300–$600 per procedure, separate from the pellets themselves, and are needed every 3–6 months.
Pharmacy markup and location: Compounding pharmacies set their own prices. A specialty pharmacy that ships nationally may charge differently than a local compounding shop. There is no standardized pricing.
Provider consultation fees: Many compounding-focused providers charge cash-pay consultation rates of $150–$400 per visit because patients on compounded regimens often don’t have insurance reimbursement for the visits either. This is a hidden cost many people don’t factor in when comparing options.
For a detailed, state-level breakdown of what patients actually report paying, our How Much Does BHRT Cost? A State-by-State Guide gives you real numbers by region.
Access Differences: Who Can Get Each Option and Where
Access differences between compounded and FDA-approved BHRT go well beyond cost. Each path has different gatekeepers, geographic constraints, and logistical requirements.
FDA-approved BHRT access: Any licensed physician, nurse practitioner, or other prescribing provider can write a prescription for FDA-approved hormone therapies, and any pharmacy — including major chains like CVS, Walgreens, and Costco — can fill it. Telehealth platforms have further expanded access: patients in most states can consult with a provider online and have their prescription sent to a local or mail-order pharmacy within days. The barrier to access is primarily finding a provider willing to prescribe, not finding a pharmacy to fill.
Compounded BHRT access: Compounded preparations require a prescribing provider experienced with compounding — and then a compounding pharmacy capable of making the specific formulation ordered. Not every state has robust compounding pharmacy infrastructure. Many patients work with pharmacies that ship across state lines, which is legal but adds shipping time and cost. The provider side can also be more restrictive: many conventional OB-GYNs and primary care doctors don’t prescribe compounded hormones, steering patients toward integrative medicine practitioners, functional medicine doctors, or specialized hormone clinics — many of whom operate on cash-pay models.
The practical result: getting started with compounded BHRT often requires more effort, more provider searching, and more upfront expense. For many patients, that extra friction is worth it — particularly those who need truly custom dosing or specific hormone combinations that don’t exist commercially. For others, it’s an unnecessary barrier when an FDA-approved option would serve them just as well. Our deep dive on BHRT and Compounding Pharmacies: What You Should Know covers what to look for in a reputable compounding pharmacy if you do go that route.
Side-by-Side Comparison: Compounded vs. FDA-Approved BHRT
Use this reference table to quickly compare the two paths across the factors that matter most:
| Factor | FDA-Approved BHRT | Compounded BHRT |
|---|---|---|
| Monthly cost (with insurance) | $10–$40 | Not covered (full cash pay) |
| Monthly cost (without insurance) | $20–$350 (generic vs. brand) | $30–$250+ |
| Insurance coverage | Yes, most commercial + Medicare | Rarely, if ever |
| Customization | Limited to commercial options | Highly customizable |
| Regulatory oversight | Full FDA approval | Not FDA-approved; pharmacy-regulated |
| Available delivery forms | Patches, gels, pills, rings, inserts | Creams, troches, injections, pellets, more |
| Pharmacy access | Any licensed pharmacy | Specialty compounding pharmacy required |
| Pellet therapy option | No | Yes (add $300–$600 per insertion) |
| Combined hormone formulas | Limited | Available (e.g., estradiol + testosterone cream) |
| Provider network | Most prescribers | Integrative/functional medicine focus |
| Quality consistency | Standardized, batch-tested | Variable; PCAB accreditation improves this |
The bottom line in plain terms: If you have insurance, FDA-approved BHRT is almost always cheaper and easier to access. If you need customization that doesn’t exist commercially, compounded BHRT is often worth the higher out-of-pocket cost and added effort.
Frequently Asked Questions
Is compounded BHRT cheaper than FDA-approved hormone therapy?
Compounded BHRT can cost anywhere from $30 to $200 per month depending on the formulation, hormones included, and pharmacy. FDA-approved hormone therapies vary widely too — from $10 with insurance to $300 or more out-of-pocket. Compounded options often appear cheaper upfront, but insurance rarely covers them, so the true out-of-pocket cost can be comparable or higher than covered FDA-approved therapies.
Does insurance cover compounded BHRT?
Most commercial insurance plans do not cover compounded BHRT because these preparations lack FDA approval. FDA-approved bioidentical hormones — such as estradiol patches, gels, and micronized progesterone — are frequently covered by insurance and Medicare Part D, making them significantly less expensive after coverage is applied. Always verify with your insurer before choosing a therapy.
Why do some doctors prefer compounded BHRT over FDA-approved options?
Some providers prefer compounded BHRT because it allows them to customize hormone combinations, dosage strengths, and delivery forms not available commercially — for example, combining estradiol and testosterone in a single cream. This flexibility can be valuable for patients with allergies to inactive ingredients or those who need doses outside the standard commercial range.
Is compounded BHRT safe compared to FDA-approved hormone therapy?
FDA-approved hormone therapies have undergone rigorous testing for safety, efficacy, and consistent potency. Compounded preparations are not FDA-approved and are not required to meet the same standardized testing. However, compounding pharmacies accredited by organizations like PCAB are held to higher quality standards. Discuss the quality assurance practices of any compounding pharmacy with your provider.
Ready to Explore BHRT?
Now that you understand how compounded vs. FDA-approved BHRT cost compares — and what drives those differences — the next step is figuring out which path fits your symptoms, your insurance situation, and your budget. Use our free BHRT Cost Estimator to build a realistic monthly budget based on your state, hormone needs, and insurance status. And when you’re ready to find a provider who will actually listen and work with you, our BHRT Provider Directory can connect you with knowledgeable practitioners near you — or via telehealth. You deserve care that takes your symptoms seriously.
The content on this site is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any hormone therapy. Individual results vary.
Common Questions About Compounded vs. FDA-Approved BHRT Costs
How do I know if my insurance covers hormone therapy?
Call the member services number on the back of your insurance card and ask specifically whether estradiol patches, estradiol gel, and micronized progesterone (Prometrium) are covered under your formulary and at what tier. Most plans cover at least one FDA-approved bioidentical estrogen option. Compounded hormones are almost universally excluded.
Can I switch from compounded BHRT to an FDA-approved version to save money?
Yes, many patients make this switch successfully — especially those who started on compounded therapy and later wanted to reduce costs. The transition usually involves working with your provider to find the closest FDA-approved equivalent in dose and delivery method. Some adjustment period is normal and expected as your body responds to the new formulation.
Why doesn’t Medicare cover compounded hormones?
Medicare does not cover compounded medications because they are not FDA-approved drugs and therefore cannot be included on Medicare Part D formularies. This is a federal regulatory requirement, not a discretionary coverage decision. However, Medicare Part D does cover many FDA-approved bioidentical hormones like estradiol patches and Prometrium at standard formulary copays.
What’s the cheapest way to get bioidentical hormone therapy?
The least expensive path for most people is an FDA-approved bioidentical hormone — such as a generic estradiol patch or gel — filled at a pharmacy using your insurance coverage or a GoodRx discount code. Patients without insurance can often get generic estradiol for $20–$60 per month this way. If you need customization that requires compounding, shopping multiple compounding pharmacies for pricing is worthwhile, as costs can vary significantly.
Is it worth paying more for compounded BHRT if I can get FDA-approved options cheaper?
It depends on your specific needs. If an FDA-approved option matches your required hormone, dose, and delivery form, paying more for a compounded version generally offers no proven additional benefit. However, if you need a hormone combination, dose, or delivery format that doesn’t exist commercially — or if you have an allergy to a standard inactive ingredient — compounded BHRT may be the only option, making the higher cost justified.
References
-
North American Menopause Society. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society.” Menopause, 2022. https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
-
U.S. Food and Drug Administration. “Bio-Identical Hormones: A Closer Look.” FDA.gov, 2022. https://www.fda.gov/consumers/consumer-updates/bio-identical-hormones-closer-look
-
Endocrine Society. “Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.” The Journal of Clinical Endocrinology & Metabolism, 2016. https://www.endocrine.org/clinical-practice-guidelines/compounded-bioidentical-hormones
-
Mayo Clinic Staff. “Bioidentical hormones: Are they safer?” Mayo Clinic, 2023. https://www.mayoclinic.org/diseases-conditions/menopause/expert-answers/bioidentical-hormones/faq-20058460
-
Pinkerton, JoAnn V. “Hormone Therapy for Postmenopausal Women.” New England Journal of Medicine, 2020. https://pubmed.ncbi.nlm.nih.gov/32433834/
Medical Disclaimer: The content on this site is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any hormone therapy. Individual results vary.